Norhydrocodone
| Clinical data | |
|---|---|
| Other names | (5α)-3-Methoxy-4,5-epoxymorphinan-6-one | 
| Dependence liability | High | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H19NO3 | 
| Molar mass | 285.343 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Norhydrocodone is the major metabolite of the opioid analgesic hydrocodone. It is formed from hydrocodone in the liver via N-demethylation predominantly by CYP3A4. Unlike hydromorphone, a minor metabolite of hydrocodone, norhydrocodone is described as inactive. However, norhydrocodone is actually an agonist of the μ-opioid receptor with similar potency to hydrocodone, but has been found to produce only minimal analgesia when administered peripherally to animals. This is likely due to poor blood-brain-barrier and thus central nervous system penetration.